Formulation & Delivery Europe 2026 consolidates every pillar of modern drug product development into one integrated programme. Advanced biologics formulation, small‑molecule delivery innovation, high‑concentration injectables, intranasal and inhaled delivery, device‑integrated systems, next‑gen RNA and oligonucleotide modalities, nanotechnology‑enabled strategies, AI‑driven formulation modelling, and analytical developability workflows operate as a single continuum—reflecting how formulation, delivery science and regulatory readiness now function as a unified discipline.

The event convenes senior drug‑product developers and technical leaders from global pharma, biotech and academia. Sessions present high‑value case studies spanning biologics, RNA, cell and gene therapies, peptides, PROTACs, molecular glues and smart devices. Attendees gain the intelligence required to benchmark formulation strategies, validate modality‑specific delivery decisions, and stay aligned with the direction of industry‑leading product development teams.

To find out more or register, click here.